Table 3.
Study | Year | Patients (n) | Inclusion time (hours) | Inclusion criteria | Neuroimaging exclusion criteria | |
---|---|---|---|---|---|---|
Clinical | Neuroimaging | |||||
DAWN (38) | 2018 | 206 | 6–24 |
|
|
|
DEFUSE 3 (39) | 2018 | 182 | 6–16 |
|
|
|
EXTEND-IA (41) | 2015 | 70 | 0–6 |
|
|
|
t-PA, tissue plasminogen activator; NIHSS, National Health Institute Stroke Severity Score; MCA, middle cerebral artery, with M1 and M2 segments; NCCT, noncontrast enhanced computed tomography; CTP, computed tomography perfusion imaging; MRP, magnetic resonance perfusion imaging; ICA, internal carotid artery; CTA, computed tomographic angiography; MRA, magnetic resonance angiography; ASPECTS, Alberta Stroke Program Early CT Score; MRI, magnetic resonance imaging.